BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1625 related articles for article (PubMed ID: 8646581)

  • 1. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up.
    Seregard S; Kock E
    Acta Ophthalmol Scand; 1995 Aug; 73(4):340-4. PubMed ID: 8646581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation.
    Cohen VM; Carter MJ; Kemeny A; Radatz M; Rennie IG
    Acta Ophthalmol Scand; 2003 Aug; 81(4):383-8. PubMed ID: 12859266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traumatic enucleation for posterior uveal melanoma.
    Specht CS; McLean IW; Biscoe BW
    Am J Ophthalmol; 1990 Nov; 110(5):518-21. PubMed ID: 2240138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors following enucleation of 111 uveal melanomas.
    Coleman K; Baak JP; Van Diest P; Mullaney J; Farrell M; Fenton M
    Br J Ophthalmol; 1993 Nov; 77(11):688-92. PubMed ID: 8280680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term prognosis of 29 patients with uveal malignant melanoma who were operated on by local resection or enucleation].
    Fujishiro T; Kojima T
    Nippon Ganka Gakkai Zasshi; 2008 Oct; 112(10):847-54. PubMed ID: 18949909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma.
    Luyten GP; Mooy CM; Eijkenboom WM; Stijnen T; Hellemons LP; Luider TM; de Jong PT
    Am J Ophthalmol; 1995 Jun; 119(6):786-91. PubMed ID: 7785695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma.
    Seddon JM; Albert DM; Lavin PT; Robinson N
    Arch Ophthalmol; 1983 Dec; 101(12):1894-9. PubMed ID: 6651594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
    Seregard S; Oskarsson M; Spångberg B
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matched group study of preenucleation radiotherapy versus enucleation alone for primary malignant melanoma of the choroid and ciliary body.
    Augsburger JJ; Lauritzen K; Gamel JW; Lowry JC; Brady LW
    Am J Clin Oncol; 1990 Oct; 13(5):382-7. PubMed ID: 2220658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma.
    Augsburger JJ; Gamel JW; Lauritzen K; Brady LW
    Am J Ophthalmol; 1990 May; 109(5):585-92. PubMed ID: 2333923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factor study of survival after enucleation for juxtapapillary melanomas.
    Weinhaus RS; Seddon JM; Albert DM; Gragoudas ES; Robinson N
    Arch Ophthalmol; 1985 Nov; 103(11):1673-7. PubMed ID: 4062633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma.
    van den Bosch T; Vaarwater J; Verdijk R; Muller K; Kiliç E; Paridaens D; de Klein A; Naus N
    Acta Ophthalmol; 2015 Sep; 93(6):555-60. PubMed ID: 25879399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective study of uveal melanoma].
    Tóth J
    Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative survival rates after alternative therapies for uveal melanoma.
    Seddon JM; Gragoudas ES; Egan KM; Glynn RJ; Howard S; Fante RG; Albert DM
    Ophthalmology; 1990 Jun; 97(6):769-77. PubMed ID: 2374681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.